CDH17 and gastric cancer: This insight has led researchers to explore CAR-T cells that target CDH17 for the treatment of colorectal, small cell lung, and gastric cancer [36, 37], suggesting that CDH17 may similarly mediate stemness and chemoresistance in CTC-TJH-01 cell clusters.